drug

PF-08653945

1 story · latest Jul 24, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Pfizer

Timeline

Pfizer week: AML donor-leukocyte trial posts results; three early trials advance

Jul 24Weekly roundup, 4 itemsgemtuzumab ozogamicin PF-08653945

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.